(Q43827163)

27 November 2017

title

Olanzapine in the treatment of anxiety symptoms due to Alzheimer's disease: a post hoc analysis (English)

1 reference

27 November 2017

0 references

J Mintzer

1

1 reference

27 November 2017

W Faison

2

1 reference

27 November 2017

J S Street

3

1 reference

27 November 2017

V K Sutton

4

1 reference

27 November 2017

A Breier

5

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

International Journal of Geriatric Psychiatry

27 November 2017

published in

1 reference

27 November 2017

volume

16 Suppl 1

1 reference

27 November 2017

page(s)

S71-7

1 reference

A rating scale for drug-induced akathisia

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS568%3E3.0.CO%3B2-M

Clinical features and pharmacologic treatment of behavioral symptoms of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS568%3E3.0.CO%3B2-M

A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS568%3E3.0.CO%3B2-M

A pilot study of haloperidol treatment of psychosis and behavioral disturbance in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS568%3E3.0.CO%3B2-M

A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS568%3E3.0.CO%3B2-M

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS568%3E3.0.CO%3B2-M

Buspirone in the Management of Agitation and Aggression Associated With Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS568%3E3.0.CO%3B2-M

A naturalistic study of trazodone in the treatment of behavioral complications of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS568%3E3.0.CO%3B2-M

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS568%3E3.0.CO%3B2-M

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS568%3E3.0.CO%3B2-M

The spectrum of behavioral changes in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS568%3E3.0.CO%3B2-M

The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS568%3E3.0.CO%3B2-M

Effects of Buspirone on Agitation Associated With Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS568%3E3.0.CO%3B2-M

Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS568%3E3.0.CO%3B2-M

Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS568%3E3.0.CO%3B2-M

The use of the neuropsychiatric inventory in nursing home residents. Characterization and measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS568%3E3.0.CO%3B2-M

10.1002/1099-1166(200112)16:1+<::AID-GPS568>3.0.CO;2-M

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference